WHO ICTRP trial

Neuronale Korrelate von dysfunktionellen Aufmerksamkeitskomponenten bei…

EUCTR2005-003245-14-DE · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2005-003245-14-DE
Public title Neuronale Korrelate von dysfunktionellen Aufmerksamkeitskomponenten bei Patienten mit Schizophrenie: cholinerge Rezeptorsysteme und pharmakologische Therapie - Schizophrenie, Therapie von Aufmerksamkeitsstörungen
Scientific title Neuronale Korrelate von dysfunktionellen Aufmerksamkeitskomponenten bei Patienten mit Schizophrenie: cholinerge Rezeptorsysteme und pharmakologische Therapie - Schizophrenie, Therapie von Aufmerksamkeitsstörungen
Primary sponsor Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Aachen
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes
Countries Germany
Conditions Patienten mit DSM-IVTR diagnostizierter Schizophrenie
Interventions Product Name: Reminyl Product Code: Galantamin Pharmaceutical Form: Capsule, hard INN or Proposed INN: Galantamin CAS Number: 357-70-0 Current Sponsor code: Galantamin Other descriptive name: Reminyl Concentration unit: mg milligram(s)…
Registration date May 9, 2006
Target size 15
Secondary IDs DFG-KI588/2-1
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations